新辅助免疫检查点封锁增强了头癌的局部和全身瘤免疫力
Ye Zhao1, Kai W Wucherpfennig1,2,3
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
Current opinion in oncology
|April 4, 2024
概括
新辅助性免疫检查点阻塞 (ICB) 增强了抗瘤T细胞的反应,导致瘤衰退,并可能减少头部和部状细胞癌 (HNSCC) 的手术范围. 这种方法显示出有希望的生存结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 新辅助免疫检查点阻断 (ICB) 证明了在各种癌症中具有临床疗效,包括FDA批准的三阴性乳腺癌和非小细胞肺癌的指示.
- 头部和部状细胞癌 (HNSCC) 是新辅助ICB策略的活跃研究领域.
- 了解新辅助性ICB的局部和全身免疫效应对于优化治疗至关重要.
研究的目的:
- 审查HNSCC中新辅助ICB的最近临床试验数据.
- 探索新辅助ICB对HNSCC中T细胞介导免疫的局部和系统影响的机制研究.
主要方法:
- 对HNSCC中新辅助ICB的临床试验和机制研究的审查.
- 对T细胞种群的分析,包括内CD8T细胞和循环活性CD8T细胞.
主要成果:
- 新辅助性ICB显示临床活性,包括HNSCC患者的一个子集的病理下降阶段和反应.
- 机理学研究显示,组织寄存的细胞毒性CD8T细胞在瘤内扩张,以及与瘤透的淋巴细胞共享TCR序列的激活循环CD8T细胞的扩张.
- 活化循环 CD8 T 细胞的频率增加与病理反应相关.
结论:
- 短期的新辅助免疫疗法可以增加局部和全身瘤反应性T细胞种群.
- 新辅助剂ICB诱导的降级可能允许在HNSCC中进行较少的外科切除.
- 新出现的数据表明,瘤对新辅助ICB有反应的HNSCC患者的生存率有所改善.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907


